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ABSTRACT
Protein secretion is a key virulence mechanism of
pathogenic and symbiotic bacteria, which makes
the investigation of secreted proteins (‘effectors’)
crucial for understanding the molecular bacterium–
host interactions. Effective (http://effectors.org) is a
database of predicted bacterial secreted proteins,
implementing two complementary prediction
strategies for protein secretion: the identification
of eukaryotic-like protein domains and the recogni-
tion of signal peptides in amino acid sequences. The
Effective web portal provides user-friendly tools for
browsing and retrieving comprehensive pre-
calculated predictions for whole bacterial genomes
as well as for the interactive prediction of effectors
in user-provided protein sequences.
INTRODUCTION
Bacterial protein secretion is a key virulence mechanism of
pathogens and symbionts (1). Thereby effector proteins
are transported from the bacterial cytosol into the extra-
cellular medium as well as directly into the eukaryotic host
cell (2). Eased uptake of the pathogen, manipulation of
the immune response and preventing apoptosis of the
infected host cell (3) are examples of the complex effects
that are triggered by secreted bacterial proteins. For
a better understanding of pathogenic organisms and the
processes associated with virulence and infection on the
molecular level, effectors are among the most important
research targets. Their investigation promises novel routes
for diagnostics and drug development, as they may offer
pathogen-speciﬁc treatment of infections (4). Up to now,
seven different bacterial secretion systems and the Sec
pathway have been so far described as molecular ways
of transport (1). Each of them is speciﬁc in terms of
molecular structure and mechanism of translocation.
Whereas, e.g. the Sec pathway is capable of transporting
proteins into the extracellular medium, the syringe-like
type III secretion system (TTSS) injects effectors directly
into the host cell. The molecular recognition of effectors
by the secretion machineries is not completely solved. For
systems of types I, II, III, IV, V and the Sec pathway,
it has been shown that signal peptides in effectors are im-
portant for their secretion (5).
To date, characterized effectors show high evolutionary
divergence (6). Therefore, similarity-based approaches
of transferring the functional annotation from well-
characterized proteins to homologous sequences in other
species have only limited power. Consequently, effectors
have to be experimentally detected and functionally
characterized for each pathogen. With only a small
number of known effectors (7), there is a high demand
for computer-based approaches for the prediction of can-
didate effector proteins. These bioinformatics methods can
provide valuable support for experiments and target
pre-selection (8). Starting points for bioinformatics
analyses are the unique features of effector protein
sequences. For two secretion systems, it is possible to
predicteffectorswithhighaccuracybasedontheassociated
signal peptide. For effectors secreted by the Sec pathway,
thissignalisaccuratelydetectedbySignalP (9).Alsoforthe
TTSS, a signal peptide in the N-terminal sequences of the
effector proteins could be found (10–12). For secretion
systems I, II, IV and V, there is to date no general
method capable of identifying the respective signal
sequence, nor is any method available that offers a
large-scale signal-independent approach to effector
identiﬁcation.
In a number of single-organism studies, many effectors
have been shown to contain diverse protein domain
signatures that are typically found in eukaryotes (13–15).
An example is the ankyrin-rich repeat domain that was
found in proteins secreted via the type IV secretion
system to disrupt the function of various eukaryotic
factors in host cells (16). To date, the knowledge about
these eukaryotic-like domains occurring in effector
proteins is restricted to a small number of exemplary
organisms and domains. The bioinformatic identiﬁcation
of eukaryotic-like domains can be performed by
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in a representative number of genomes of pathogens,
non-pathogens and eukaryotes. All protein domains that
occur in eukaryotes and pathogens, but not or only rarely
in non-pathogens, could be detected this way. Despite its
great potential, there has no large-scale bioinformatic
resource yet been described making use of eukaryotic-like
protein domains for the identiﬁcation of novel effectors.
Here, we describe Effective, a novel and unique
database of predicted secreted proteins in bacteria.
Effective predicts putative effectors comprehensively by
a combination of two complementary approaches: (i) in-
dependently from the mechanism of transport by identify-
ing eukaryotic-like protein domains and (ii) by detecting
the two known types of signal peptides regardless the
presence of well-conserved protein domains. As SignalP
(9) is the most widely used method predicting Sec
pathway signals and EffectiveT3 represents the only
type-III signal prediction method that was explicitly
shown to be taxonomically universal (10), these two
programs have been utilized.
METHODS AND IMPLEMENTATION
The Effective database and its web portal have been
implemented using the JAVA programming language, a
MySQL relational database and Java Server Pages.
The genome repository
Proteome data and features from a variety of different
resources are integrated into the portal and structured in
a genome repository: we derived the annotated proteins of
all publicly available completely sequenced genomes listed
in the RefSeq database (17), as well as all 11912 domain
signatures detected by Pfam (18) using the Simap database
(19). For genomes included in the eggNOG Clusters of
Orthologous Groups (20), we have additionally stored
reduced proteomes containing only evolutionary
conserved sequences being member of a COG or NOG.
This approach eliminates ORFans representing possible
gene over-predictions and thus improves the determin-
ation of domain enrichment scores (see below). All organ-
isms covered by the genome repository are classiﬁed into
147 eukaryotes and, according to the Resource on
Microbial Genomes (21), into 466 pathogenic, 121 symbi-
otic and 358 non-pathogenic bacteria. For all genomes,
all genomic sequences including plasmids were considered.
Furthermore, we identiﬁed those Gram-negative bacteria
that harbor a probably functional TTSS. For this purpose,
we used annotations from the KEGG database (22) to
identify the proteomes that contain at least 2/3 of the
proteins being part of the molecular TTSS apparatus.
Regular updates of the genome repository are performed
every 3 months.
Integration of signal-based effector prediction methods
The prediction of Sec pathway signal peptides was per-
formed using the program SignalP (9), whereas
EffectiveT3 has been used to predict type-III secreted
proteins (10). Precalculations of the TTSS predictions
have been performed for all 89 genomes in the repository
harboring a probably functional TTSS.
Large-scale identiﬁcation of eukaryotic-like protein
domains
We implemented a systematic, large-scale approach to
identify eukaryotic-like protein domains based on the
comparison of domain frequencies in all genomes con-
tained in the genome repository. The domain score enrich-
ment score allows distinguishing between protein domains
that are uniformly distributed over different classes of
organisms and eukaryotic-like domains that are enriched
in the proteomes of pathogenic bacteria. In order to elim-
inate the inﬂuence of bacterial contaminations in eukary-
otic genomes, the calculation was restricted to protein
domains that are detected in pathogenic genomes as well
as in at least 10 eukaryotic genomes. To estimate the back-
ground model for each remaining domain, the average and
standard deviation of its frequencies in all non-pathogenic
genomes are calculated. For genomes included in the
eggNOG Clusters of Orthologous Groups (20),
frequencies according to the reduced proteomes contain-
ing only evolutionary conserved sequences have been
determined additionally. For each pathogen genome, the
domain enrichment score S of each domain has been
calculated as the number of standard deviations  in
which the domain frequency in that particular pathogenic
genome n differs from the average background frequency
 in non-pathogen genomes: S=(n)/. Thereby it
directly reﬂects the enrichment of a particular
eukaryotic-like domain in proteins of a particular patho-
genic genome. Although the distribution of domain occur-
rences across genomes has varying shapes, manual
inspection of domain enrichment scores has shown that
the domain enrichment scores typically show the charac-
teristics of Z-scores and can be considered signiﬁcant if
higher than 3–5.
For user-provided data, sequences are scanned for
Pfam domain signatures using HmmScan (18). Detected
domains are evaluated based on the precalculated domain
enrichment scores in the Effective database, considering
the maximum score that is achieved by the particular
domain in all pathogen genomes.
RESULTS
Effective is a database of predicted secreted proteins
in bacterial genomes. We have implemented two comple-
mentary prediction strategies for protein secretion: (i) the
recognition of signal peptides in amino acid sequences and
(ii) the identiﬁcation of eukaryotic-like protein domains.
The current version of Effective contains 587 complete
genomes of pathogenic and symbiotic bacteria, in which
421774 effector proteins have been predicted in total by at
least one method. As to be expected from the limited
coverage of any of the prediction methods, many predic-
tions are only supported by one or two methods
(Figure 1); e.g. many proteins containing eukaryotic-like
domains do not have a detectable secretion signal for the
Sec and type III pathways. Contrarily, many proteins
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conserved protein domain, preventing the detection
of eukaryotic-like function. This limitation is an
intrinsic consequence of signature-based approaches.
Consequently, the prediction of protein secretion by
Effective does not require any consensus between the com-
plementary prediction approaches but considers any single
positive prediction to be of biological relevance.
The overlap between predictions of Sec and type-III
signal peptides is surprisingly high, as these two types of
signal peptides should be incompatible to each other.
However, due to the limited knowledge about the molecu-
lar principles of effector recognition by these secretion
systems, we cannot yet discard one positive signal in the
presence of the other. As the real number of secreted
proteins is unknown for all genomes of pathogens and
symbionts, the amount of false positives contributing to
the surprisingly high number of predictions, only
supported by SignalP (334629) or EffectiveT3 (31350),
cannot be reliably determined. Considering the limited
accuracy of both programs, subsequent ﬁltering of the
predictions (e.g. discarding functionally well-annotated,
probably not-secreted proteins) is highly recommended.
The ongoing improvement of bioinformatic tools for the
identiﬁcation of signal peptides will probably improve the
situation within the next years.
Predicted effectors in complete genomes of pathogenic
and symbiotic bacteria
The applicability of the prediction approaches imple-
mented in Effective is different: whereas Sec dependent
secretion is a widespread feature of pathogens and sym-
bionts and eukaryotic-like domains can be encoded in any
of their genomes, type-III secreted proteins can only be
expected in genomes of Gram-negative bacteria encoding
a type-III secretion system that is likely to be functional.
Effective therefore provides different tools accessing
precalculated secreted proteins.
For all 89 genomes of Gram-negative bacteria that
encode a probably functional type III secretion system,
the results of EffectiveT3 predicting type-III effectors are
included in the precalculated ﬁles available for download.
These results contain the accessions and descriptions of all
annotated proteins in the respective genomes, the
EffectiveT3 scores and the secretion prediction for each
protein according to the selective default threshold and
standard prediction model.
By selecting the organism of interest, eukaryotic-like
domains and signal peptides of the Sec pathway can be
retrieved from the Effective database for each of the 587
genomes of pathogenic and symbiotic bacteria. In order to
provide consistent scores across genomes, domain enrich-
ment scores based on the total number of annotated
proteins are always provided. If the genome is contained
in the eggNOG database of Clusters of Orthologous
Groups (20), additional domain enrichment scores accord-
ing to the conserved proteome are given. As the further
exploration and biologic interpretation of eukaryotic-like
protein domains is facilitated by dedicated domain reports
in Effective (see below), we provide these precalculated
results online through interactive web pages that link
any predicted domain to its status report page.
Comprehensive information about eukaryotic-like domains
The identiﬁcation of eukaryotic-like domains, based on
the score resulting from the taxonomic occurrence of
each domain, is a unique feature of the Effective
database. Speciﬁc report pages are therefore provided
for each protein domain that has been detected in at
least one pathogenic genome with a signiﬁcant domain
enrichment score of 4 or higher. For any domain, the
numbers and lists of pathogenic, non-pathogenic and eu-
karyotic genomes encoding at least one protein having this
domain are indicated. As the frequencies of the domain in
these organisms determine the domain enrichment score,
this information allows the user to understand why
Effective has identiﬁed the particular domain as
eukaryotic-like. For each listed pathogen genome, lists
of proteins containing the particular eukaryotic-like
domain, actually representing predicted effector proteins,
can be obtained.
Interactive prediction of secreted proteins in
user-provided sequences
The Effective database offers a user-friendly interface for
the interactive prediction of secreted proteins in sequence
data uploaded by the user. Compared to the precalculated
data, this tool allows the user to control all prediction
settings and to integrate the results from the different
methods into one sorted table. Input data can contain
even thousands of protein sequences; however, the user
should be aware of the calculation time necessary to
perform automatic domain annotation and signal
peptide detection.
For the analysis of input sequence data, the user can
choose from any combination of the three different
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Figure 1. Numbers of predicted effectors in 587 genomes of pathogenic
and symbiotic bacteria, indicated by supporting prediction method.
EffectiveT3 has only been applied to 89 genomes of Gram-negative
bacteria that encode a type III secretion system.
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proteins, (ii) prediction of type-III secreted proteins and
(iii) identiﬁcation of eukaryotic-like protein domains. The
conﬁgurable parameters of these methods are explained in
a detailed ‘Help’-section on the website. Proteins that have
received positive predictions from at least one selected
method are provided in tabular form for further visual
inspection on the website and for download in Excel
format.
Prediction tools for type-III secreted proteins and
communication with the scientiﬁc community
The Effective database portal provides the EffectiveT3
program as a stand-alone application. By downloading
and locally executing the program, or by starting it
using Java WebStart, conﬁdential sequence data can be
analyzed without transferring it over the Internet to the
Effective database. The list of known type-III secreted
proteins that have been used for training the current
EffectiveT3 classiﬁcation models can be displayed or
downloaded by the user. As further improvements of
EffectiveT3 rely mostly on the availability of more com-
prehensive training data, users may submit the amino acid
sequences newly characterized effectors via the Effective
database to the developers of the EffectiveT3 software.
Update of data and prediction methods
Updates of the genome repository and all precalculated
predictions in the Effective database are automatically
conducted quarterly. If new prediction methods for
secreted proteins become available, e.g. for the identiﬁca-
tion of signal sequences in type-IV secreted proteins, the
portal architecture allows for their easy integration. All
updates of the Effective database will be announced to
the users via the ‘News’ section of the portal and the
Effective mailing list.
CONCLUSIONS AND FUTURE WORK
The Effective database is the ﬁrst bioinformatic resource
combining two complementary approaches for the predic-
tion of bacterial secreted proteins: (i) function-based pre-
diction by identiﬁcation of eukaryotic-like domains and
(ii) prediction based on signal peptides leading to trans-
port by protein secretion systems. None of the two
strategies can, by principle, achieve complete coverage;
therefore, their integration in a single resource is beneﬁcial
for the comprehensive annotation of putative effectors in
genomes and proteomes. The user-friendly web portal of
the Effective database offers a versatile toolbox for
generating new effector candidates and for target selection
toward experimental investigation of putative secreted
proteins. As the development and improvement of com-
putational methods for effector prediction is a vital area of
research, new methods can be expected to become avail-
able within the next years. The Effective database provides
a powerful framework for their easy integration and will
therefore make relevant new methods accessible to the
users of the database.
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